Ace Therapeutics, a leading innovator in preclinical research models, has unveiled a suite of customizable in vivo and in vitro models designed to accelerate Alzheimer’s disease (AD) drug development. With neurodegenerative disorders posing a growing global health challenge, Ace Therapeutics’ advanced platforms provide researchers with highly predictive, translatable tools to...
English
العربية
Français
Español
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt